Latest Regulatory Engagement News

Aura Energy announces a strategic collaboration with Neu Horizon Uranium Ltd to advance uranium mining in Sweden, aligning with the Swedish government’s plans to lift its uranium mining ban and bolster nuclear energy production.

Predictive Discovery faces revocation of key exploration permits in Guinea but retains critical Bankan project permits, with exploitation application progressing through regulatory channels.

Besra Gold has appointed David Potter as Chair and Sean Williamson as Director, bolstering its board with seasoned expertise as it transitions from exploration to gold production at the Jugan Project.

Leeuwin Metals has confirmed extensive shallow, high-grade gold mineralisation across a 1.6km trend at its Evanston Prospect within the Marda Gold Project, Western Australia, setting the stage for a busy exploration season.

Chalice Mining reports significant metallurgical improvements at its Gonneville Project, boosting metal recoveries and revealing a promising iron byproduct that could enhance project economics.

Lakes Blue Energy is progressing regulatory approvals and has locked in a drilling rig for its Wombat-5 gas well, while reporting a $1.48 million operating cash outflow and maintaining $3.55 million in cash at quarter-end.

Mesoblast has commercially launched Ryoncil in the US for pediatric acute GVHD, backed by a strong cash position and advancing multiple cell therapy programs.

Alterity Therapeutics reports compelling Phase 2 clinical trial results for ATH434 in Multiple System Atrophy, alongside a significant capital raise strengthening its financial position for upcoming regulatory milestones.

Trigg Minerals has solidified its ownership of the Wild Cattle Creek antimony deposit with NSW government approval and confirmed high-grade antimony and tungsten mineralisation beneath the site. The company also expanded its New South Wales footprint through strategic acquisitions of historic gold and antimony projects.

Nagambie Resources reported significant new antimony-gold intersections at its Nagambie Mine and joined a US Department of Defence consortium, positioning itself amid soaring antimony prices and strategic demand. The company also advanced funding arrangements and plans a resource update in the June quarter.

Optiscan Imaging Ltd has revealed its next-generation InForm™ pathology imaging device and strengthened its executive team, while reporting a robust cash position supported by a $1.775 million R&D tax refund for the quarter ended 31 March 2025.

Novatti Group Limited has achieved a key turnaround milestone by reporting positive cash EBITDA of $100k in Q3 FY25, alongside record quarterly revenue of $13.4 million and improved margins in its core Payments AU/NZ business.